实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2014年
6期
600-605
,共6页
彭景%郭艳%何长龙%徐宝艳%胡亚君%毛青
彭景%郭豔%何長龍%徐寶豔%鬍亞君%毛青
팽경%곽염%하장룡%서보염%호아군%모청
血清丙氨酸氨基转移酶升高%不明原因%临床特征%肝组织病理学
血清丙氨痠氨基轉移酶升高%不明原因%臨床特徵%肝組織病理學
혈청병안산안기전이매승고%불명원인%림상특정%간조직병이학
Elevated serum alanine aminotransferase levels%Cryptogenic%Clinical features%Liver pathology
目的:总结不明原因肝炎患者的临床特征,制定不明原因肝炎的诊断路径。方法收集2010年~2013年血清丙氨酸氨基转移酶(ALT)升高患者,经过逐次筛查、甄别、随访三个阶段,应用问诊、体格检查、影像学检查、高敏度方法检测病毒核酸以及基因位点检测、肝组织病理学和免疫组织化学、相关疾病评分系统等诊断方法,总结不明原因肝炎的临床特征,制定规范的针对不明原因肝炎的诊断路径。结果在筛查阶段,1000例血清ALT升高患者中仍有143例(14.3%)不能明确病因;在甄别阶段和随访阶段,又确诊21例(HBV感染3例,病毒性肝炎4例,自身免疫性肝病13例,药物性肝损伤1例),最终仍有122例(12.2%)病因不明;122例不明原因肝炎患者血清ALT和总胆红素(TBIL)分别为(640.01±596.67) IU/L和(118.41±142.64)μmol/L;在这些患者中,53.3%(65/122)有乏力、71.3%(87/122)有消化道症状和50.0%(61/122)有黄疸;87.5%(70/80)肝组织病理学改变为轻、中度损害,91.3%(73/80)以慢性改变为主;72.1%(88/122)患者预后良好。结论尽管有详尽的筛查流程和采用高敏度的检测手段,仍有一些血清ALT升高患者在现阶段得不到明确的诊断。
目的:總結不明原因肝炎患者的臨床特徵,製定不明原因肝炎的診斷路徑。方法收集2010年~2013年血清丙氨痠氨基轉移酶(ALT)升高患者,經過逐次篩查、甄彆、隨訪三箇階段,應用問診、體格檢查、影像學檢查、高敏度方法檢測病毒覈痠以及基因位點檢測、肝組織病理學和免疫組織化學、相關疾病評分繫統等診斷方法,總結不明原因肝炎的臨床特徵,製定規範的針對不明原因肝炎的診斷路徑。結果在篩查階段,1000例血清ALT升高患者中仍有143例(14.3%)不能明確病因;在甄彆階段和隨訪階段,又確診21例(HBV感染3例,病毒性肝炎4例,自身免疫性肝病13例,藥物性肝損傷1例),最終仍有122例(12.2%)病因不明;122例不明原因肝炎患者血清ALT和總膽紅素(TBIL)分彆為(640.01±596.67) IU/L和(118.41±142.64)μmol/L;在這些患者中,53.3%(65/122)有乏力、71.3%(87/122)有消化道癥狀和50.0%(61/122)有黃疸;87.5%(70/80)肝組織病理學改變為輕、中度損害,91.3%(73/80)以慢性改變為主;72.1%(88/122)患者預後良好。結論儘管有詳儘的篩查流程和採用高敏度的檢測手段,仍有一些血清ALT升高患者在現階段得不到明確的診斷。
목적:총결불명원인간염환자적림상특정,제정불명원인간염적진단로경。방법수집2010년~2013년혈청병안산안기전이매(ALT)승고환자,경과축차사사、견별、수방삼개계단,응용문진、체격검사、영상학검사、고민도방법검측병독핵산이급기인위점검측、간조직병이학화면역조직화학、상관질병평분계통등진단방법,총결불명원인간염적림상특정,제정규범적침대불명원인간염적진단로경。결과재사사계단,1000례혈청ALT승고환자중잉유143례(14.3%)불능명학병인;재견별계단화수방계단,우학진21례(HBV감염3례,병독성간염4례,자신면역성간병13례,약물성간손상1례),최종잉유122례(12.2%)병인불명;122례불명원인간염환자혈청ALT화총담홍소(TBIL)분별위(640.01±596.67) IU/L화(118.41±142.64)μmol/L;재저사환자중,53.3%(65/122)유핍력、71.3%(87/122)유소화도증상화50.0%(61/122)유황달;87.5%(70/80)간조직병이학개변위경、중도손해,91.3%(73/80)이만성개변위주;72.1%(88/122)환자예후량호。결론진관유상진적사사류정화채용고민도적검측수단,잉유일사혈청ALT승고환자재현계단득불도명학적진단。
Objective To investigate the clinical features in patients with cryptogenic hepatitis and establish a standardized road-map for diagnosis of them. Methods Patients with elevated serum alanine aminotransferase (ALT) levels from 2010 to 2013 were included in this study. Patients passed through screening,detailed examination,and follow-up stages as necessary. History-taking,physical examination,radiography,blood tests including highly sensitive detection of virus nucleic acid and gene locus testing,liver histopathology and immunohistochemistry and diagnostic scoring system were applied to find out the etiology. Results A total of 143 patients (14.3%) with cryptogenic hepatitis were left from 1000 individuals with elevated serum ALT levels;After detailed examination and/or follow-up for months,21 patients got diagnosis including three with hepatitis B,four with viral hepatitis,thirteen with autoimmune liver diseases,and one with drug-induced liver injury,while the causes in other 122 cases (12.2%) were still unknown;Serum ALT and TBIL levels in the 122 patients with cryptogenic hepatitis were (640.01±596.67) IU/L and (118.41±142.64)μmol/L;Out of the 122 patients,53.3%(65/122) had fatigue,71.3%(87/122) had gastrointestinal symptoms,and 50.0%(61/122)had jaundice;The liver histopathologic exam showed that 87.5% (70/80) got mild to moderate histological activity index and 72.1%(88/122)patients got good prognosis. Conclusions At present,about 10% of patients with elevated serum ALT levels are cryptogenic,although the detailed screening processes and very highly sensitive tests can be applied for the clinical practice.